Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Minimally invasive tumor ablation in the liver
Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 10/20/09
Wybranski C et al. – These techniques allow the destruction of extensive liver tumors with an acceptable toxicity profile. Necessity for a safe performance of these procedures is a close collaboration between interventional radiologist and anesthetist.
Related Articles
Immediate Microsurgical Reconstruction After Tumor Ablation Predicts Survival Among Patients with Head and Neck Carcinoma
Annals of Surgical Oncology, 10/23/09
Relevance Score: 67%
Minimally Invasive Nephron Sparing Management for Renal Tumors in Solitary Kidneys
The Journal of Urology, 10/12/09
Relevance Score: 67%
Radiofrequency ablation: another treatment option for local control of desmoid tumors
Skeletal Radiology, 10/20/09
Relevance Score: 66%
Surgical strategies for managing foraminal nerve sheath tumors: the emerging role of CyberKnife ablation
European Spine Journal, 10/13/09
Relevance Score: 66%
Hepatocellular Carcinoma With Cirrhosis: Are Patients With Neoplastic Main Portal Vein Invasion Eligible for Percutaneous Radiofrequency Ablation of Both the Nodule and the Portal Venous Tumor Thrombus
American Journal of Roentgenology, 10/08/09
Relevance Score: 66%
Today in Hepatobiliary/Pancreas...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatic Toxicities Associated with the Use of Preoperative Systemic Therapy in Patients with Metastatic Colorectal Adenocarcinoma to the Liver
The Oncologist, 12/02/09
Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers
Modern Pathology, 12/02/09
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study
The Lancet Oncology - Online First, 12/01/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole
Breast Cancer Research and Treatment, 12/02/09
A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: in vitro and in vivo activity and mechanisms of action
Breast Cancer Research and Treatment, 12/02/09
FDA Drug Approval Summary: Bevacizumab (Avastin) as Treatment of Recurrent Glioblastoma Multiforme
The Oncologist, 12/02/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


